Xiaojing Li1, Hongxia Xiang2, Wen Zhang1, Chunling Peng3. 1. Department of Anesthesiology, Qinghai Provincial People's Hospital Xining 810000, Qinghai Province, China. 2. Department of Anesthesiology, The 963 Hospital of The PLA Joint Logistics Support Force Jiamusi 154000, Heilongjiang Province, China. 3. Department of Anesthesiology, Chongqing Jiangjin District Central Hospital Chongqing 402260, China.
Abstract
OBJECTIVE: This paper aims to explore the effects of remifentanil combined with propofol on the stress responses, oxidative damage, and inflammatory responses in cardiac surgery patients. METHODS: One hundred and four patients who underwent cardiac surgery in our hospital from August 2017 to March 2019, were recruited as the study cohort and divided into control and observation groups. The 50 patients in the control group were anesthetized with fentanyl and propofol, and the 54 patients in the observation group were anesthetized with remifentanil and propofol. The general clinical data were observed and compared between the two groups. At different time points, changes in the oxidative stress response indicators (mean artery pressure (MAP) and heart rate (HR)) and in the cardiac function indexes (left ventricular ejection fraction (LVEF), stroke volume (SV), and cardiac output (CO)) were observed. The inflammatory cytokine levels (high-sensitivity C-reactive protein (hs-CRP), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α)) were analyzed using enzyme-linked immunosorbent assays (ELISA). The patients' postoperative recovery (time to spontaneous respiration, time to opening eyes, extubation time) and their Visual Analogue Scale (VAS) scores were observed. Their pain at half an hour and at 24 hours after the operation were observed, as well as their postoperative adverse reactions. RESULTS: There were no differences in the general data between the two groups (P>0.05). Compared with the patients in the control group, the patients in the observation group had better oxidative stress levels and better cardiac function indexes (P<0.05), better postoperative inflammatory cytokine levels (P<0.05), better postoperative recovery (P<0.05), lower postoperative pain scores (P<0.05), and a lower total incidence of adverse reactions (P<0.05). CONCLUSION: Remifentanil combined with propofol can effectively reduce oxidative stress and inflammatory responses in cardiac surgery patients. AJTR
OBJECTIVE: This paper aims to explore the effects of remifentanil combined with propofol on the stress responses, oxidative damage, and inflammatory responses in cardiac surgery patients. METHODS: One hundred and four patients who underwent cardiac surgery in our hospital from August 2017 to March 2019, were recruited as the study cohort and divided into control and observation groups. The 50 patients in the control group were anesthetized with fentanyl and propofol, and the 54 patients in the observation group were anesthetized with remifentanil and propofol. The general clinical data were observed and compared between the two groups. At different time points, changes in the oxidative stress response indicators (mean artery pressure (MAP) and heart rate (HR)) and in the cardiac function indexes (left ventricular ejection fraction (LVEF), stroke volume (SV), and cardiac output (CO)) were observed. The inflammatory cytokine levels (high-sensitivity C-reactive protein (hs-CRP), interleukin-10 (IL-10), and tumor necrosis factor-α (TNF-α)) were analyzed using enzyme-linked immunosorbent assays (ELISA). The patients' postoperative recovery (time to spontaneous respiration, time to opening eyes, extubation time) and their Visual Analogue Scale (VAS) scores were observed. Their pain at half an hour and at 24 hours after the operation were observed, as well as their postoperative adverse reactions. RESULTS: There were no differences in the general data between the two groups (P>0.05). Compared with the patients in the control group, the patients in the observation group had better oxidative stress levels and better cardiac function indexes (P<0.05), better postoperative inflammatory cytokine levels (P<0.05), better postoperative recovery (P<0.05), lower postoperative pain scores (P<0.05), and a lower total incidence of adverse reactions (P<0.05). CONCLUSION:Remifentanil combined with propofol can effectively reduce oxidative stress and inflammatory responses in cardiac surgery patients. AJTR
Authors: Donat R Spahn; Felix Schoenrath; Gabriela H Spahn; Burkhardt Seifert; Philipp Stein; Oliver M Theusinger; Alexander Kaserer; Inga Hegemann; Axel Hofmann; Francesco Maisano; Volkmar Falk Journal: Lancet Date: 2019-04-26 Impact factor: 79.321
Authors: Christopher Uhlig; Thomas Bluth; Kristin Schwarz; Stefanie Deckert; Luise Heinrich; Stefan De Hert; Giovanni Landoni; Ary Serpa Neto; Marcus J Schultz; Paolo Pelosi; Jochen Schmitt; Marcelo Gama de Abreu Journal: Anesthesiology Date: 2016-06 Impact factor: 7.892
Authors: Judson B Williams; Gina McConnell; J Erin Allender; Patricia Woltz; Kathy Kane; Peter K Smith; Daniel T Engelman; William T Bradford Journal: J Thorac Cardiovasc Surg Date: 2018-12-08 Impact factor: 5.209
Authors: Peter Zilla; Magdi Yacoub; Liesl Zühlke; Friedhelm Beyersdorf; Karen Sliwa; Gennadiy Khubulava; Abdelmalek Bouzid; Ana Olga Mocumbi; Devagourou Velayoudam; Devi Shetty; Chima Ofoegbu; Agneta Geldenhuys; Johan Brink; Jacques Scherman; Henning du Toit; Saeid Hosseini; Hao Zhang; Xin-Jin Luo; Wei Wang; Juan Mejia; Theodoros Kofidis; Robert S D Higgins; Jose Pomar; R Morton Bolman; Bongani M Mayosi; Rajhmun Madansein; Joseph Bavaria; Alberto A Yanes-Quintana; A Sampath Kumar; Oladapo Adeoye; Risenga Frank Chauke; David F Williams Journal: Glob Heart Date: 2018-09-20